MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$17,180K Other current assets$12,067K Prepaid expenses$3,945K Inventory$500K Accounts receivable, net$216K Total current assets$33,908K Property and equipment,net$117K Total assets$34,025K Accumulated deficit-$732,785K Total liabilities andstockholders' (deficit)...$34,025K Total stockholders'(deficit) equity-$105,543K Additionalpaid-in-capital$627,215K Common stock, 0.001 parvalue, 200,000 shares...$27K Total liabilities$139,568K Long-term debt$77,858K Total currentliabilities$54,994K Derivative liabilities$6,716K Current portion oflong-term debt$22,431K Accounts payable$16,247K Other currentliabilities-Nonrelated Party$9,750K Accrued expenses$6,388K Other currentliabilities-Related Party$178K
Balance Sheet

BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics, Inc. (BTAI)

source: myfinsight.com